Body Mass Index Review
A BMI of less than 18.5 means that a person is underweight. A BMI of between 18.5 and 24.9 is ideal. A BMI of between 25 and 29.9 is overweight. A BMI over 30 indicates obesity. Body Mass Index is a simple calculation using a person's height and weight. The formula is BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. A BMI of 25.0 or more is overweight, while the healthy range is 18.5 to 24.9. BMI applies to most adults 18-65 years. One easily forgotten reason is that your weight only indicates your body mass index (BMI), not your body composition, which is the amount of muscle versus fat you have on your body. Your body composition makes a huge difference in what you look like even though it can't be measured by the scale. A BMI of less than 18.5 means that a person is underweight. A BMI of between 18.5 and 24.9 is ideal. A BMI of between 25 and 29.9 is overweight. A BMI over 30 indicates obesity. A result between 18.5 and 24.9 means you're in the “normal” weight range for your height. If your result is under 18.5, you're considered underweight. Between 25 and 29.9 means you're considered overweight. And if your number is 30 to 35 or more, you're considered obese
High Impact List of Articles
-
Role of sodium status in the clinical management of diabetic nephropathy: interaction with RAAS-blockade efficacy
Martin H de Borst & Gerjan Navis
Review Article: Diabetes Management
-
Role of sodium status in the clinical management of diabetic nephropathy: interaction with RAAS-blockade efficacy
Martin H de Borst & Gerjan Navis
Review Article: Diabetes Management
-
An overview of non-insulin adjunctive therapies for Type 1 diabetes
Chitrabhanu Ballav & Stephen C L Gough
Review Article: Diabetes Management
-
An overview of non-insulin adjunctive therapies for Type 1 diabetes
Chitrabhanu Ballav & Stephen C L Gough
Review Article: Diabetes Management
-
Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?
Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbak, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham & Simon J Griffin
Management Perspectives: Diabetes Management
-
Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?
Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbak, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham & Simon J Griffin
Management Perspectives: Diabetes Management
-
Viruses and Type 1 diabetes: a dynamic labile equilibrium
Darius A Schneider & Matthias G von Herrath
Review Article: Diabetes Management
-
Viruses and Type 1 diabetes: a dynamic labile equilibrium
Darius A Schneider & Matthias G von Herrath
Review Article: Diabetes Management
-
The cause of Type 2 diabetes: a new paradigm
Paul Zimmet
Interview: Diabetes Management
-
The cause of Type 2 diabetes: a new paradigm
Paul Zimmet
Interview: Diabetes Management
Relevant Topics in Clinical